CERNOSTICS
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
CERNOSTICS
Industry:
Biotechnology Health Diagnostics Life Science Medical Device
Founded:
2008-01-01
Address:
Danville, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cernostics.com
Total Employee:
11+
Status:
Active
Contact:
(570)214-5123
Email Addresses:
[email protected]
Total Funding:
21.26 M USD
Technology used in webpage:
SPF Content Delivery Network Euro US Privacy User Signal Mechanism YouTube Google Analytics 4 Unified Layer LinkedIn Insights CPanel Google Conversion Linker
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Advisors List
Current Employees Featured
Founder
Investors List
Illumina Ventures
Illumina Ventures investment in Series A - Cernostics
UPMC
UPMC investment in Venture Round - Cernostics
Novitas Capital
Novitas Capital investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Venture Round - Cernostics
Geisinger Health System
Geisinger Health System investment in Series B - Cernostics
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - Cernostics
Novitas Capital
Novitas Capital investment in Series B - Cernostics
Novitas Capital
Novitas Capital investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Debt Financing - Cernostics
Official Site Inspections
http://www.cernostics.com
- Host name: a3ef2d3a3279c65d0.awsglobalaccelerator.com
- IP address: 76.223.88.164
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
